Secondary prevention of stroke is important - But all hypertensive drugs are not created equal?

被引：8

作者：

Strandberg, TE ^{[1
]}

机构：

[1] Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland

来源：

STROKE | 2005年 / 36卷 / 06期

关键词：

D O I：

10.1161/01.STR.0000166044.06026.46

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1225 / 1226

页数：2

共 16 条

[1]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[2] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Dahlöf, B ;

Devereux, RB ;

Kjeldsen, SE ;

Julius, S ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H .

LANCET, 2002, 359 (9311) :995-1003

[3] Cerebroprotection mediated by angiotensin II - A hypothesis supported by recent randomized clinical trials [J].

Fournier, A ;

Messerli, FH ;

Achard, JM ;

Fernandez, L .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (08) :1343-1347

[4] Effect of antihypertensive treatment in patients having already suffered from stroke - Gathering the evidence [J].

Gueyffier, F ;

Boissel, JP ;

Boutitie, F ;

Pocock, S ;

Coope, J ;

Cutler, J ;

Ekbom, T ;

Fagard, R ;

Friedman, L ;

Kerlikowske, K ;

Perry, M ;

Prineas, R ;

Schron, E .

STROKE, 1997, 28 (12) :2557-2562

[5] Hypertension, angiotensin, and stroke: Beyond blood pressure [J].

Iadecola, C ;

Gorelick, PB .

STROKE, 2004, 35 (02) :348-350

[6] Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes [J].

Jandeleit-Dahm, KAM ;

Tikellis, C ;

Reid, CM ;

Johnston, CI ;

Cooper, ME .

JOURNAL OF HYPERTENSION, 2005, 23 (03) :463-473

[7]

LIU LS, 1995, CHINESE MED J-PEKING, V108, P710

[8] Do thiazide diuretics confer specific protection against strokes? [J].

Messerli, FH ;

Grossman, E ;

Lever, AF .

ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (21) :2557-2560

[9]

PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556, DOI 10.1016/S0140-6736(01)06178-5

[10] Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention -: Principal results of a prospective randomized controlled study (MOSES) [J].

Schrader, J ;

Lüders, S ;

Kulschewski, A ;

Hammersen, F ;

Plate, K ;

Berger, J ;

Zidek, W ;

Dominiak, P ;

Diener, HC .

STROKE, 2005, 36 (06) :1218-1224

← 1 2 →